BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26480949)

  • 1. Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes.
    Monteiro MB; Santos-Bezerra DP; Thieme K; Admoni SN; Perez RV; Machado CG; Queiroz MS; Nery M; Oliveira-Souza M; Woronik V; Passarelli M; Giannella-Neto D; Machado UF; Corrêa-Giannella ML
    Free Radic Res; 2016; 50(1):101-10. PubMed ID: 26480949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
    Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML
    Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
    Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
    J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
    Zheng M; Lv LL; Cao YH; Zhang JD; Wu M; Ma KL; Phillips AO; Liu BC
    Clin Endocrinol (Oxf); 2012 May; 76(5):657-64. PubMed ID: 21824169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender- and disease-specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy.
    Tobino K; Muso E; Iwasaki Y; Yonemoto S; Kasuno K; Tsukamoto T; Nakamura H; Tomino Y
    Nephrology (Carlton); 2015 May; 20(5):368-74. PubMed ID: 25615414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
    Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
    Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX.
    Ji L; Wang Q; Huang F; An T; Guo F; Zhao Y; Liu Y; He Y; Song Y; Qin G
    Oxid Med Cell Longev; 2019; 2019():3286928. PubMed ID: 30962862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
    Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
    Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.
    De Marinis Y; Cai M; Bompada P; Atac D; Kotova O; Johansson ME; Garcia-Vaz E; Gomez MF; Laakso M; Groop L
    Kidney Int; 2016 Feb; 89(2):342-53. PubMed ID: 26806835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, localization, and function of the thioredoxin system in diabetic nephropathy.
    Advani A; Gilbert RE; Thai K; Gow RM; Langham RG; Cox AJ; Connelly KA; Zhang Y; Herzenberg AM; Christensen PK; Pollock CA; Qi W; Tan SM; Parving HH; Kelly DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):730-41. PubMed ID: 19211714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.
    Lim JY; Yoon SO; Hong SW; Kim JW; Choi SH; Cho JY
    World J Gastroenterol; 2012 Oct; 18(39):5581-8. PubMed ID: 23112551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study.
    Nielsen SE; Hansen HP; Jensen BR; Parving HH; Rossing P
    Nephron Clin Pract; 2011; 118(2):c130-5. PubMed ID: 21160226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats.
    Liu JH; Liu DF; Wang NN; Lin HL; Mei X
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):528-33. PubMed ID: 21615774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin, thioredoxin interacting protein and transducer and activator of transcription 3 in gestational diabetes.
    Pasternak Y; Ohana M; Biron-Shental T; Cohen-Hagai K; Benchetrit S; Zitman-Gal T
    Mol Biol Rep; 2020 Feb; 47(2):1199-1206. PubMed ID: 31848914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
    Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
    Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy.
    Wang G; Lai FM; Chow KM; Kwan BC; Pang WF; Luk CC; Leung CB; Li PK; Szeto CC
    Diabetes Metab Res Rev; 2015 Oct; 31(7):699-706. PubMed ID: 25865428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between diabetic nephropathy and insulin resistance, inflammation, Trx, Txnip, CysC and serum complement levels.
    Xu LL; Gao W; Chen ZM; Shao KK; Wang YG; -L Cui L; Guo NZ
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11700-11706. PubMed ID: 33275238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of telmisartan in Type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein.
    Wu J; Lin H; Liu D; Liu J; Wang N; Mei X; Sun J; Yang G; Zhang X
    J Endocrinol Invest; 2013; 36(7):453-9. PubMed ID: 23211392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.